Background: The Birmingham Vasculitis Activity Score (BVAS) and Vasculitis Damage Index (VDI) are validated clinical assessment tools for the systemic vasculitides, which are characterized by episodes of disease activity and accrual of irreversible damage. However use of BVAS and VDI is limited, partly due to lack of training but also lack of perceived need. The increasing use of biologic agents in vasculitis means that these tools can provide quantifiable evaluation prior to treatment and be used to monitor response and outcome. We present pilot data on the performance of a training package including a webbased assessment of performance developed for this purpose. Methods: The training package (which consists of an introductory lecture, a manual plus 20 simple and 40 advanced vasculitis case scenarios) was tested among a group of international physicians and research nurses specialized in vasculitis during 3 clinical trial investigators' meetings, and one educational meeting for UK rheumatology fellows. The overall pass mark for each set of cases was set at 85% and 75% agreement with gold standard for BVAS and VDI respectively (and at least 50% for each individual case). In case of failure to achieve the required mark, specific cases could be reset allowing a reattempt. Initial training was performed using printed paper-cases; subsequent meetings employed a custom built interactive web-based application. The application provided immediate formal evaluation on completion and detailed feedback on performance of each evaluated case. The percentage agreement, number of attempts per case and time needed to complete the training were analysed, as well as their own feedback. Results: Over the course of 4 events 106 participants scored 5900 cases; 2600 were scored by 51 participants using the website. Of these, 33.3% passed the advanced section on their first attempt with an average mark of 92.3% (range 86.6-96.4) for BVAS and 92% (range 88.9-95.0) for VDI. Participants finished the web based assessment within approximately 4-6 hours, spending on average 4-6 minutes per case. The number of reattempts per BVAS case decreased from 1.08 (1 in 14 cases retaken) in the introductory set to 1.05 (1 in 21 cases retaken) in the advanced set, showing intra-training improvement. Overall 100% completed the training and were awarded certification.
59.2% of participants agreed that the training should be mandatory for all doctors treating vasculitis patients. Conclusion: We have developed a paper and web-based training package to enhance clinicians' ability to evaluate patients with systemic vasculitis, based on assessment of BVAS and VDI. This package is effective, easy to use, feasible and acceptable to participants to facilitate their ability to manage patients with vasculitis. Because the training is partly web based, it should be possible to provide it remotely. We are currently developing an entirely web-based system. Disclosure statement: R.P. is an employee of GSK. J.B. is an employee of GSK. T.O. is an employee of GSK. R.L. received consultancy fees from GSK. All other authors have declared no conflicts of interest. Background: GPA is a rare autoimmune systemic vasculitis considered to be the result of the interaction of environmental factors with a genetically predisposed host. Proposed environmental factors include latitude, and ultraviolet exposure. HLA-DPB1*0401 alleles have been associated with GPA. HLA allele frequencies vary between populations. For example when genetic diversity within Europe is subjected to principle component analysis, HLA is one of several genetic regions that are strongly associated with a component that runs along a north-south gradient from Norway and Sweden to Spain. The incidence of GPA is lower in non-Caucasian populations. The relative contribution of genetic and environmental factors as an explanation for geographical differences in GPA incidence is unknown. The aim of this study was to relate worldwide variations in GPA incidence to population frequencies of HLA-DPB1*0401 alleles and to geographical latitude. Methods: A literature search in PubMed was conducted with combinations of the medical subject heading terms granulomatosis with polyangiitis, Wegener's granulomatosis and epidemiology. Studies that appeared to report duplicate or overlapping populations were excluded. Studies completing recruitment before 1990 were excluded in case there are time trends in the incidence of GPA, and because the quality of the reporting was generally lower for the older studies.
HLA-DPB ALLELES AND GRANULOMATOSIS WITH POLYANGIITIS
Where more than one report existed for a single country (unless in distinct populations), then the one with a later average period of recruitment was preferred. To identify ethnically-matched HLA-DPB1*0401 population allele frequencies for each geographical region (city, province or country) identified, the Allele Frequency Net Database (www.allelefrequencies.net) was consulted. Geographical latitude was estimated for each incidence study by identifying the coordinates of the relevant geographical region, usually the reporting centre. Google Maps was used to identify latitude co-ordinates. Data were displayed graphically and linear regression was used to identify relationships between HLA-DPB1*0401 allele frequencies, geographical latitude, and the incidence of GPA in different countries. Due to heterogeneity of the GPA incidence studies and the limited number of populations with available data, formal meta-regression was not performed.
Results: Eighteen studies were included for which there was adequate information about classification method, and denominator population. 11 were from Europe, 2 from the Americas and 5 from Australasia. For i186 Downloaded from https://academic.oup.com/rheumatology/article-abstract/53/suppl_1/i186/1796516 by guest on 05 April 2019
